These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28075379)

  • 1. Veterinary Compounding: Regulation, Challenges, and Resources.
    Davidson G
    Pharmaceutics; 2017 Jan; 9(1):. PubMed ID: 28075379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compounding for animal patients: contemporary issues.
    Lust E
    J Am Pharm Assoc (2003); 2004; 44(3):375-84; quiz 384-6. PubMed ID: 15191248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
    Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
    Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extemporaneous compounding in veterinary practice: a New Zealand perspective.
    Gargiulo DA; Chemal C; Joda L; Lee YJ; Pilkington M; Haywood A; Garg S
    N Z Vet J; 2013 Nov; 61(6):311-5. PubMed ID: 23544952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veterinary compounding in small animals: a clinical pharmacologist's perspective.
    Boothe DM
    Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):1129-73, viii. PubMed ID: 16984830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Current Landscape of Veterinary Compounding in the Pharmacy Setting.
    Gochenauer AE; Holmes ER; Barber KE; Forsythe LR
    Int J Pharm Compd; 2019; 23(5):422-427. PubMed ID: 31513542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active pharmaceutical ingredients available as substances for extemporaneous preparation in veterinary medicine in the Czech Republic.
    Sklenář Z; Horáčková K; Bakhouche H
    Ceska Slov Farm; 2014 Apr; 63(2):71-4. PubMed ID: 24870551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compounding and Extralabel Use of Drugs in Exotic Animal Medicine.
    Powers LV; Davidson G
    Vet Clin North Am Exot Anim Pract; 2018 May; 21(2):195-214. PubMed ID: 29655467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Current Landscape of Veterinary Compounding in the Veterinary Setting.
    Gochenauer AE; Rishniw M; Holmes ER; Forsythe LR
    Int J Pharm Compd; 2019; 23(5):428-433. PubMed ID: 31513543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
    Lam MS
    Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Extent of Extemporaneous Preparation and Regulatory Framework of Extemporaneous Compounding in Latvia.
    Kiseļova O; Mauriņa B; Šidlovska V; Zvejnieks J
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31454896
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy.
    Pinkerton JV; Pickar JH
    Menopause; 2016 Feb; 23(2):215-23. PubMed ID: 26418479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
    Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
    Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. United States pharmacopeia convention standards and clinical information for compounded medications used in veterinary medicine.
    Deveau I
    Int J Pharm Compd; 2007; 11(5):357-62. PubMed ID: 23969515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Extemporaneous Prescriptions Prescribed by Dermatovenerologists in Latvia and Comparison with Standardized Compounded Preparation Monographs of Germany and USA.
    Kiseļova O; Mauriņa B; Šidlovska V
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical compounding or pharmaceutical manufacturing? A regulatory perspective.
    Timko RJ; Crooker PE
    Int J Pharm Compd; 2014; 18(2):101-11. PubMed ID: 24881112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Pharmaceutical Compounding Training in the Australian Undergraduate Pharmacy Curricula.
    Kosari S; Buss VH; Peterson GM; Yee KC; Naunton M; Bushell M; Chiu L; Thomas J
    Pharmacy (Basel); 2020 Feb; 8(1):. PubMed ID: 32110956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality, safety and efficacy in the 'off-label' use of medicines.
    Kairuz TE; Gargiulo D; Bunt C; Garg S
    Curr Drug Saf; 2007 Jan; 2(1):89-95. PubMed ID: 18690954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.